The chitosan/carboxymethyl cellulose/montmorillonite scaffolds incorporated with epigallocatechin-3-gallate-loaded chitosan microspheres for promoting osteogenesis of human umbilical cord-derived mesenchymal stem cell

Abstract

Epigallocatechin-3-gallate (EGCG) is a plant-derived flavonoid compound with the ability to promote the differentiation of human bone marrow-derived mesenchymal stem cells (MSCs) into osteoblasts. However, the effect of EGCG on the osteogenic differentiation of the human umbilical cord-derived mesenchymal stem cells (HUMSCs) is rarely studied. Therefore, in this study, the osteogenic effects of EGCG are studied in the HUMSCs by detecting cell proliferation, alkaline phosphatase (ALP) activity, calcium deposition and the expression of relevant osteogenic markers. The results showed that EGCG can promote the proliferation and osteogenic differentiation of the HUMSCs in vitro at a concentration of 2.5–5.0 μM. Unfortunately, the EGCG is easily metabolized by cells during cell culture, which reduces its bioavailability. Therefore, in this paper, EGCG-loaded microspheres (ECM) were prepared and embedded in chitosan/carboxymethyl cellulose/montmorillonite (CS/CMC/MMT) scaffolds to form CS/CMC/MMT-ECM scaffolds for improving the bioavailability of EGCG. The HUMSCs were cultured on CS/CMC/MMT-ECM scaffolds to induce osteogenic differentiation. The results showed that the CS/CMC/MMT-ECM scaffold continuously released EGCG for up to 22 days. In addition, CS/CMC/MMT-ECM scaffolds can promote osteoblast differentiation. Taken together, the present study suggested that entrainment of ECM into CS/CMC/MMT scaffolds was a prospective scheme for promotion osteogenic differentiation of the HUMSCs.

Keywords

Epigallocatechin-3-gallate / Chitosan microspheres / Scaffolds / Osteogenesis

References

[1] Azizian S, Hadjizadeh A, Niknejad H. Chitosan-gelatin porous scaffold incorporated with chitosan nanoparticles for growth factor delivery in tissue engineering. Carbohydr Polym, 2018, 202: 315-322.

[2] Cabezas J, Rojas D, Navarrete F, Ortiz R, Rivera G, Saravia F, Rodriguez-Alvarez L, Castro FO. Equine mesenchymal stem cells derived from endometrial or adipose tissue share significant biological properties, but have distinctive pattern of surface markers and migration. Theriogenology, 2018, 106: 93-102.

[3] Chen H, Xing X, Tan H, Jia Y, Zhou T, Chen Y, Ling Z, Hu X. Covalently antibacterial alginate-chitosan hydrogel dressing integrated gelatin microspheres containing tetracycline hydrochloride for wound healing. Mat Sci Eng C, 2017, 70: 287-295.

[4] Chen PF, Xia C, Mo J, Mei S, Lin XF, Fan SW. Interpenetrating polymer network scaffold of sodium hyaluronate and sodium alginate combined with berberine for osteochondral defect regeneration. Mater Sci Eng C-Mater Biol Appl, 2018, 91: 190-200.

[5] Cheng YH, Dong JC, Bian Q. Small molecules for mesenchymal stem cell fate determination. World J Stem Cells, 2019, 11: 1084-1103.

[6] Coimbra P, Ferreira P, de Sousa HC, Batista P, Rodrigues MA, Correia IJ, Gil MH. Preparation and chemical and biological characterization of a pectin/chitosan polyelectrolyte complex scaffold for possible bone tissue engineering applications. Int J Biol Macromol, 2011, 48: 112-118.

[7] Cui ZK, Kim S, Baljon JJ, Doroudgar M, Lafleur M, Wu BM, Aghaloo T, Lee M. Design and characterization of a therapeutic non-phospholipid liposomal nanocarrier with osteoinductive characteristics to promote bone formation. ACS Nano, 2017, 11: 8055-8063.

[8] Fabian L, Langenbach J. Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro. World J Stem Cells, 2013, 10: 1023-1034.

[9] Freeman FE, Stevens HY, Owens P, Guldberg RE, McNamara LM. Osteogenic differentiation of mesenchymal stem cells by mimicking the cellular niche of the endochondral template. Tissue Eng Pt A, 2016, 22: 1176-1190.

[10] Geisberger G, Gyenge EB, Hinger D, Kach A, Maake C, Patzke GR. Chitosan-thioglycolic acid as a versatile antimicrobial agent. Biomacromol, 2013, 14: 1010-1017.

[11] Gu LH, Zhang TT, Li Y, Yan HJ, Qi H, Li FR. Immunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic rats. Cell Mol Immunol, 2015, 12: 444-455.

[12] Haroun AA, Gamal-Eldeen A, Harding DR. Preparation, characterization and in vitro biological study of biomimetic three-dimensional gelatin-montmorillonite/cellulose scaffold for tissue engineering. J Mater Sci Mater Med, 2009, 20: 2527-2540.

[13] Hosogane N, Huang ZP, Rawlins BA, Liu X, Boachie-Adjei O, Boskey AL, Zhu W. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell B, 2010, 42: 1132-1141.

[14] Hou Z, Sang SM, You H, Lee MJ, Hong J, Chin KV, Yang CS. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res, 2005, 65: 8049-8056.

[15] Hsu SH, Wang MC, Lin JJ. Biocompatibility and antimicrobial evaluation of montmorillonite/chitosan nanocomposites. Appl Clay Sci, 2012, 56: 53-62.

[16] Hung CN, Mar K, Chang HC, Chiang YL, Hu HY, Lai CC, Chu RM, Ma CM. A comparison between adipose tissue and dental pulp as sources of MSCs for tooth regeneration. Biomaterials, 2011, 32: 6995-7005.

[17] Jin P, Wu H, Xu G, Zheng L, Zhao J. Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study. Cell Tissue Res, 2014, 356: 381-390.

[18] Katti KS, Katti DR, Dash R. Synthesis and characterization of a novel chitosan/montmorillonite/hydroxyapatite nanocomposite for bone tissue engineering. Biomed Mater, 2008, 3: 34122-34125.

[19] Kevadiya BD, Rajkumar S, Bajaj HC, Chettiar SS, Gosai K, Brahmbhatt H, Bhatt AS, Barvaliya YK, Dave GS, Kothari RK. Biodegradable gelatin-ciprofloxacin-montmorillonite composite hydrogels for controlled drug release and wound dressing application. Coll Surf B Biointerfaces, 2014, 122: 175-183.

[20] Koc DA, Elcin AE, Elcin YM. Strontium-modified chitosan/montmorillonite composites as bone tissue engineering scaffold. Mater Sci Eng C Mater Biol Appl, 2018, 89: 8-14.

[21] Komoto D, Furuike T, Tamura H. Preparation of polyelectrolyte complex gel of sodium alginate with chitosan using basic solution of chitosan. Int J Biol Macromol, 2019, 126: 54-59.

[22] Kong Y, Zhao Y, Li D, Shen HW, Yan MM. Dual delivery of encapsulated BM-MSCs and BMP-2 improves osteogenic differentiation and new bone formation. J Biomed Mater Res A, 2019, 107: 2282-2295.

[23] Koshani R, Tavakolian M, Ven T. Natural emulgel from dialdehyde cellulose for lipophilic drug delivery. ACS Sustain Chem Eng, 2021, 9: 8680-8692.

[24] Kosinski M, Figiel-Dabrowska A, Lech W, Wieprzowski L, Strzalkowski R, Strzemecki D, Cheda L, Lenart J, Domanska-Janik K, Sarnowska A. Bone defect repair using a bone substitute supported by mesenchymal stem cells derived from the umbilical cord. Stem Cells Int, 2020, 2020: 18-29.

[25] Kulandaivelu K, Mandal AKA. Improved bioavailability and pharmacokinetics of tea polyphenols by encapsulation into gelatin nanoparticles. IET Nanobiotechnol, 2016, 11: 469-476.

[26] Lee H, Bae S, Yoon Y. The anti-adipogenic effects of (-)epigallocatechin gallate are dependent on the WNT/beta-catenin pathway. J Nutr Biochem, 2013, 24: 1232-1240.

[27] Leena RS, Vairamani M, Selvamurugan N. Alginate/gelatin scaffolds incorporated with silibinin-loaded chitosan nanoparticles for bone formation in vitro. Colloid Surface B, 2017, 158: 308-318.

[28] Lei C, Liu G, Gan Y, Fan Q, Fei Y, Zhang X, Tang T, Dai KJb,. The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats. Stem Cells Int, 2012, 33: 5076-5084.

[29] Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials, 2005, 26: 3919-3928.

[30] Li M, Xu JX, Shi TX, Yu HY, Bi JP, Chen GZ. Epigallocatechin-3-gallate augments therapeutic effects of mesenchymal stem cells in skin wound healing. Clin Exp Pharmacol Physiol, 2016, 43: 1115-1124.

[31] Li Q, Tan W, Zhang C, Gu G, Guo Z. Synthesis of water soluble chitosan derivatives with halogeno-1,2,3-triazole and their antifungal activity. Int J Biol Macromol, 2016, 91: 623-629.

[32] Liu Z, Ge Y, Zhang L, Wang Y, Guo C, Feng K, Yang S, Zhai Z, Chi Y, Zhao J, Liu F. The effect of induced membranes combined with enhanced bone marrow and 3D PLA-HA on repairing long bone defects in vivo. J Tissue Eng Regen Med, 2020, 14: 1403-1414.

[33] Liuyun J, Yubao L, Chengdong X. Preparation and biological properties of a novel composite scaffold of nano-hydroxyapatite/chitosan/carboxymethyl cellulose for bone tissue engineering. J Biomed Sci, 2009, 16: 65-78.

[34] Lu XL, Ding Y, Niu QN, Xuan SJ, Yang Y, Jin YL, Wang H. ClC-3 chloride channel mediates the role of parathyroid hormone [1–34] on osteogenic differentiation of osteoblasts. Plos One, 2017, 12: 269-283.

[35] Menon AH, Soundarya SP, Sanjay V, Chandran SV, Balagangadharan K, Selvamurugan N. Sustained release of chrysin from chitosan-based scaffolds promotes mesenchymal stem cell proliferation and osteoblast differentiation. Carbohyd Polym, 2018, 195: 356-367.

[36] Nagamura-Inoue T, He HJWJSC. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. J Biomed Sci, 2014, 6: 195-202.

[37] Neybecker P, Henrionnet C, Pape E, Grossin L, Mainard D, Galois L, Loeuille D, Gillet P, Pinzano A. Respective stemness and chondrogenic potential of mesenchymal stem cells isolated from human bone marrow, synovial membrane, and synovial fluid. Stem Cell Res Ther, 2020, 11: 316-328.

[38] Nistor MT, Vasile C, Chiriac AP. Hybrid collagen-based hydrogels with embedded montmorillonite nanoparticles. Mater Sci Eng C Mater Biol Appl, 2015, 53: 212-221.

[39] Pittenger MF, Discher DE, Peault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. Npj Regen Med, 2019, 4: 1278-1289.

[40] Rostami Z, Khorashadizadeh M, Naseri M. Immunoregulatory properties of mesenchymal stem cells: micro-RNAs. Immunol Lett, 2020, 219: 34-45.

[41] Safari B, Davaran S, Aghanejad A. Osteogenic potential of the growth factors and bioactive molecules in bone regeneration. Int J Biol Macromol, 2021, 175: 544-557.

[42] Sainitya R, Sriram M, Kalyanaraman V, Dhivya S, Saravanan S, Vairamani M, Sastry TP, Selvamurugan N. Scaffolds containing chitosan/carboxymethyl cellulose/mesoporous wollastonite for bone tissue engineering. Int J Biol Macromol, 2015, 80: 481-488.

[43] Sato K, Mera H, Wakitani S, Takagi M. Effect of epigallocatechin-3-gallate on the increase in type II collagen accumulation in cartilage-like MSC sheets. Biosci Biotechnol Biochem, 2017, 81: 1241-1245.

[44] Shariati A, Nemati R, Sadeghipour Y, Yaghoubi Y, Baghbani R, Javidi K, Zamani M, Hassanzadeh A. Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier. Eur J Cell Biol, 2020, 99: 159-172.

[45] Su N, Jin M, Chen L. Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models. Bone Res, 2014, 2: 978-991.

[46] Sun XX, Shen JF, Yu D, Ouyang XK. Preparation of pH-sensitive Fe3O4@C/carboxymethyl cellulose/chitosan composite beads for diclofenac sodium delivery. Int J Biol Macromol, 2019, 127: 594-605.

[47] Thakur G, Singh A, Singh I. Chitosan-montmorillonite polymer composites: formulation and evaluation of sustained release tablets of aceclofenac. Sci Pharm, 2015, 84: 603-617.

[48] Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells—current trends and future prospective. Biosci Rep, 2015, 35: 487-496.

[49] Vila-Parrondo C, Garcia-Astrain C, Liz-Marzan LM. Colloidal systems toward 3D cell culture scaffolds. Adv Colloid Interfac, 2020, 283: 2497-2508.

[50] Wang DW, Wang YH, Xu SH, Wang F, Wang BM, Han K, Sun DQ, Li LX. Epigallocatechin-3-gallate protects against hydrogen peroxide-induced inhibition of osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Stem Cells Inter, 2016, 138: 1087-1096.

[51] Watanabe J, Yamada M, Niibe K, Zhang M, Kondo T, Ishibashi M, Egusa H. Preconditioning of bone marrow-derived mesenchymal stem cells with N-acetyl-L-cysteine enhances bone regeneration via reinforced resistance to oxidative stress. Biomaterials, 2018, 185: 25-38.

[52] Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. TiEng, 2005, 11: 1-18.

[53] Wu L, Li XX, Guan TM, Chen Y, Qi CW. 3D bioprinting of tissue engineering scaffold for cell culture. Rapid Prototyp J, 2020, 26: 835-840.

[54] Xi J, Li Q, Luo X, Li J, Guo L, Xue H, Wu G. Epigallocatechin-3-gallate protects against secondary osteoporosis in a mouse model via the Wnt/β-catenin signaling pathway. Mol Med Report, 2018, 18: 4555-4562.

[55] Yan S, Zhang Q, Wang J, Liu Y, Lu S, Li M, Kaplan DL. Silk fibroin/chondroitin sulfate/hyaluronic acid ternary scaffolds for dermal tissue reconstruction. Acta Biomater, 2013, 9: 6771-6782.

[56] Yang T, Cui XJ, Kao YB, Wang HY, Wen JH. Electrospinning PTMC/Gt/OA-HA composite fiber scaffolds and the biocompatibility with mandibular condylar chondrocytes. Coll Surf A, 2016, 499: 123-130.

[57] Yang J, Zhou M, Li WD, Lin F, Shan GQ. Preparation and evaluation of sustained release platelet-rich plasma-loaded gelatin microspheres using an emulsion method. ACS Omega, 2020, 5: 27113-27118.

[58] Yang S, Zhu B, Yin P, Zhao LS, Wang YZ, Fu ZG, Dang RJ, Xu J, Zhang JJ, Wen N. Integration of human umbilical cord mesenchymal stem cells-derived exosomes with hydroxyapatite-embedded hyaluronic acid-alginate hydrogel for bone regeneration. Acs Biomater Sci Eng, 2020, 6: 1590-1602.

[59] Yao ZA, Chen FJ, Cui HL, Lin T, Guo N, Wu HG. Efficacy of chitosan and sodium alginate scaffolds for repair of spinal cord injury in rats. Neural Regen Res, 2018, 13: 502-509.

[60] Ylostalo JH. 3D stem cell culture. Stem Cells Inter, 2020, 9: 2178-2188.

[61] Zhang Y, Yang WX, Devit A, Beucken JJJP. Efficiency of coculture with angiogenic cells or physiological BMP-2 administration on improving osteogenic differentiation and bone formation of MSCs. J Biomed Mater Res A, 2019, 107: 643-653.

[62] Zhang N, Zhu JY, Ma QC, Zhao Y, Wang YC, Hu XY, Chen JH, Zhu W, Han ZC, Yu H. Exosomes derived from human umbilical cord MSCs rejuvenate aged MSCs and enhance their functions for myocardial repair. Stem Cell Res Ther, 2020, 11: 129-138.

[63] Zhou C, Lin Y. Osteogenic differentiation of adipose-derived stem cells promoted by quercetin. Cell Proliferat, 2014, 47: 124-132.

[64] Zhou Y, Wu Y, Jiang X, Zhang X, Xia L, Lin K, Xu Y. The effect of quercetin on the osteogenesic differentiation and angiogenic factor expression of bone marrow-derived mesenchymal stem cells. Plos One, 2015, 10: 129593-129605.